Search research articles
Contact Us
Filters
Showing results (1-10 of 71) with videos related to
Page
of 8
Sort By:
Pharmaceuticals (Basel, Switzerland)
|
February 26, 2025
Feature Reviews in Medicinal Chemistry
Mary J Meegan
Pharmaceuticals (Basel, Switzerland)
|
April 23, 2022
Special Issue "Anticancer Drugs 2021"
Mary J Meegan, Niamh M O'Boyle
Pharmaceuticals (Basel, Switzerland)
|
September 19, 2019
Special Issue "Anticancer Drugs"
Mary J Meegan, Niamh M O'Boyle
Acta Crystallographica. Section E, Crystallographic Communications
|
August 27, 2020
Azetidin-2-ones: structures of anti-mitotic compounds based on the 1-(3,4,5-tri-meth-oxy-phen-yl)azetidin-2-one core
Brendan Twamley, Niamh M O'Boyle, Mary J Meegan
The Journal of Pharmacology and Experimental Therapeutics
|
September 11, 2015
Combretastatins: more than just vascular targeting agents?
Lisa M Greene, Mary J Meegan, Daniela M Zisterer
Current Topics in Medicinal Chemistry
|
March 7, 2006
Estrogen receptors: molecular interactions, virtual screening and future prospects
Andrew J S Knox, Mary J Meegan, David G Lloyd
Expert Opinion on Drug Discovery
|
March 15, 2013
Virtual screening of the estrogen receptor
Andrew Js Knox, Yidong Yang, David G Lloyd, et al.
Journal of Chemical Information and Modeling
|
November 29, 2005
Considerations in compound database preparation--"hidden" impact on virtual screening results
Andrew J S Knox, Mary J Meegan, Giorgio Carta, et al.
European Journal of Medicinal Chemistry
|
October 1, 2016
Piperlongumine (piplartine) and analogues: Antiproliferative microtubule-destabilising agents
Mary J Meegan, Seema Nathwani, Brendan Twamley, et al.
Chemistryopen
|
July 25, 2022
Application of 2D EXSY and qNMR Spectroscopy for Diastereomeric Excess Determination Following Chiral Resolution of β-Lactams
Eavan C McLoughlin, John E O'Brien, Cristina Trujillo, et al.
Page
of 8
Search research articles
Search
Showing results (1-10 of 71) with videos related to
Sort By:
Page
of 8
Pharmaceuticals (Basel, Switzerland)
|
February 26, 2025
Feature Reviews in Medicinal Chemistry
Mary J Meegan
Pharmaceuticals (Basel, Switzerland)
|
April 23, 2022
Special Issue "Anticancer Drugs 2021"
Mary J Meegan, Niamh M O'Boyle
Pharmaceuticals (Basel, Switzerland)
|
September 19, 2019
Special Issue "Anticancer Drugs"
Mary J Meegan, Niamh M O'Boyle
Acta Crystallographica. Section E, Crystallographic Communications
|
August 27, 2020
Azetidin-2-ones: structures of anti-mitotic compounds based on the 1-(3,4,5-tri-meth-oxy-phen-yl)azetidin-2-one core
Brendan Twamley, Niamh M O'Boyle, Mary J Meegan
The Journal of Pharmacology and Experimental Therapeutics
|
September 11, 2015
Combretastatins: more than just vascular targeting agents?
Lisa M Greene, Mary J Meegan, Daniela M Zisterer
Current Topics in Medicinal Chemistry
|
March 7, 2006
Estrogen receptors: molecular interactions, virtual screening and future prospects
Andrew J S Knox, Mary J Meegan, David G Lloyd
Expert Opinion on Drug Discovery
|
March 15, 2013
Virtual screening of the estrogen receptor
Andrew Js Knox, Yidong Yang, David G Lloyd, et al.
Journal of Chemical Information and Modeling
|
November 29, 2005
Considerations in compound database preparation--"hidden" impact on virtual screening results
Andrew J S Knox, Mary J Meegan, Giorgio Carta, et al.
European Journal of Medicinal Chemistry
|
October 1, 2016
Piperlongumine (piplartine) and analogues: Antiproliferative microtubule-destabilising agents
Mary J Meegan, Seema Nathwani, Brendan Twamley, et al.
Chemistryopen
|
July 25, 2022
Application of 2D EXSY and qNMR Spectroscopy for Diastereomeric Excess Determination Following Chiral Resolution of β-Lactams
Eavan C McLoughlin, John E O'Brien, Cristina Trujillo, et al.
Page
of 8